Titel

Merkliste
1 Ergebnisse

Initial report of a clinical trial evaluating the safety an..:

Fuhua Lin ; Chengcheng Guo ; Qunying Yang...
http://www.jglioma.com/article.asp?issn=2589-6113;year=2022;volume=5;issue=1;spage=29;epage=38;aulast=Lin. , 2022

Link: https://doi.org/10.4103/glioma.glioma_6_22

RT Journal
T1 <Title>Initial report of a clinical trial evaluating the safety and efficiency of neoadjuvant camrelizumab and apatinib in patients with recurrent high-grade gliomas: A prospective, phase II, single-arm study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:80629bf777d141b2ac828b4b01248b11&Exemplar=1&LAN=DE
				
A1 Fuhua Lin
A1 Chengcheng Guo
A1 Qunying Yang
A1 Yinsheng Chen
A1 Chao Ke
A1 Ke Sai
A1 Ji Zhang
A1 Xiaobing Jiang
A1 Wanming Hu
A1 Shaoyan Xi
A1 Jian Zhou
A1 Depei Li
A1 Zhihuan Zhou
A1 Qinqin Zhao
A1 Xi Cao
A1 Zhong-ping Chen
PB Wolters Kluwer Medknow Publications
YR 2022
K1 apatinib
K1 camrelizumab
K1 neoadjuvant therapy
K1 recurrent glioma
K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
K1 RC254-282
JF http://www.jglioma.com/article.asp?issn=2589-6113;year=2022;volume=5;issue=1;spage=29;epage=38;aulast=Lin
LK http://dx.doi.org/https://doi.org/10.4103/glioma.glioma_6_22
DO https://doi.org/10.4103/glioma.glioma_6_22
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)